Cancer Data
About the Community
The Cancer Data Community aims to enhance the accessibility of cancer data, including genomics, imaging, and clinical data, by developing federated and interoperable systems for securely sharing, processing, and reusing data across borders. This supports advanced research and innovation. A key activity is identifying “Gold Standard” use cases from ELIXIR Nodes (e.g., research institutes, hospitals, and clinics) that work with cancer-related data.
The ELIXIR Cancer Data Community is actively involved in the EOSC4Cancer project, which aims to define well-curated datasets to facilitate robust analytics and AI, covering the entire patient journey from prevention to treatment. This initiative brings together 29 organizations from 13 countries, leveraging research infrastructures and collaborating with major international coalitions such as ICGC-Argo, GA4GH, 1+MG/B1MG, the European Genomic Data Infrastructure (GDI), Cancer Core Europe, the European Cancer Information System, the European Network of Cancer Registries, and the Innovative Partnership for Action Against Cancer Joint Action.
Contribution of ELIXIR Italy
Italy is using the Recovery Fund, or Next Generation EU, to enhance digital infrastructure in healthcare, including genomic data storage. This effort is coordinated by the CNR and involves 20 partner institutions. ELIXIR-IT collaborates with the consortium “Alleanza Contro il Cancro” to bring technological and organisational innovation from basic research to clinical practice, raising and standardising the level of assistance, care, and rehabilitation for cancer patients across the country.
